Phoenix PharmaLabs
Business Services · Utah, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
999 W 1500 S Ste 600, Woods Cross, Utah,...Phone Number
(312) 943-1123Website
www.phoenixpharmalabs.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Phoenix PharmaLabs
Phoenix PharmaLabs, Inc. is a privately held, pre-clinical stage drug development company focusing on the development and commercialization of new non-addictive treatments for pain and new therapies for the treatment of opiate addiction. They are based in Woods Cross, Utah.Explore more
Phoenix PharmaLabs Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Phoenix PharmaLabs your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Phoenix PharmaLabs launches new products
Funding: Get notified immidiatlly once Phoenix PharmaLabs has new funding data
Phoenix PharmaLabs, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Phoenix PharmaLabs
Check out if Phoenix PharmaLabs is spiking on competitors!
Check if Phoenix PharmaLabs has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Phoenix PharmaLabs recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Phoenix PharmaLabs had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Phoenix PharmaLabs
Find 2 more new buyers
Compare Similar Companies to Phoenix PharmaLabs
Compare insights from companies similar to Phoenix PharmaLabs, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Phoenix PharmaLabs is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Phoenix PharmaLabs is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Phoenix PharmaLabs.
Phoenix PharmaLabs financials insights
Gather financial insights about Phoenix PharmaLabs, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Private Equity
$1.1M
2021
Other Financing Round
$1.1M
Phoenix PharmaLabs Tech Stack
A closer look at the technologies used by Phoenix PharmaLabs
See more technologies
Phoenix PharmaLabs News & Media
Phoenix PharmaLabs Awarded $8.7 Million Grant from NIDA to Study Compound for Treatment of Cocaine Use Disorder
WOODS CROSS, Utah--(BUSINESS WIRE)--Phoenix PharmaLabs, Inc. (https://phoenixpharmalabs.com), a private company developing potent, non-addictive treatments for pain and addiction, today announced the receipt of an $8.7 million grant from the National Institute on Drug Abuse (NIDA). The primary focus of the grant is to study the company’s lead compound, PPL-138, for the treatment of cocaine use disorder (CUD). The grant has been awarded as part of NIH’s HEAL – The Helping to End Addiction Long-TPhoenix PharmaLabs Successfully Completes Second Oversubscribed Netcapital Offering Raising more than $1 million to Fund Continued Development of Company’s Two Non-Addictive Opioid Compounds for Acute and Chronic Pain
WOODCROSS, Utah--(BUSINESS WIRE)-- #PPL103--Phoenix PharmaLabs completes second oversubscribed Reg CF to fund continued development of its non addictive drugs for acute and chronic painPhoenix PharmaLabs Strengthens its Position as a Developer of Next Generation Pain Pharmaceuticals with the Acquisition of a Portfolio of NOP/Mu Agonist Compounds
SALT LAKE CITY--(BUSINESS WIRE)-- #PPL--Phoenix PharmaLabs completes acquisition of portfolio of NOP/Mu Agonist Compounds adding to portfolio of-addictive pain drugs under developmentPhoenix PharmaLabs Announces New Investment Offering with Netcapital
SALT LAKE CITY--(BUSINESS WIRE)-- #netcapital--Phoenix PharmaLabs - developer of non-addictive opioids - launches new equity offering on Netcapital platform.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Phoenix PharmaLabs
Sign Up For FreeTo access detailed company insights
Phoenix PharmaLabs, Inc. is a privately held, pre-clinical stage drug development company focusing on the development and commercialization of new non-addictive treatments for pain and new therapies for the treatment of opiate addiction. They are based in Woods Cross, Utah.... Read More
